Molecule Group (LON:MOL – Get Free Report) insider Brendan OBrien purchased 23,200 shares of the company’s stock in a transaction dated Monday, October 12th. The shares were purchased at an average price of GBX 212 per share, for a total transaction of £49,184.
Molecule Group Stock Performance
Molecule Group stock traded down GBX 5 during midday trading on Tuesday, reaching GBX 202. The company’s stock had a trading volume of 48,903 shares, compared to its average volume of 38,997. Molecule Group has a fifty-two week low of GBX 202 and a fifty-two week high of GBX 220. The company has a market cap of £55.10 million and a P/E ratio of -10.31.
Wall Street Analysts Forecast Growth
Separately, Canaccord Genuity Group reiterated a “buy” rating and set a GBX 308 target price on shares of Molecule Group in a research report on Tuesday, September 29th. One investment analyst has rated the stock with a Buy rating. Based on data from MarketBeat, Molecule Group presently has a consensus rating of “Buy” and a consensus target price of GBX 308.
Featured Stories
- Five stocks we like better than Molecule Group
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures its Cash Flow Runway
- Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs
- IonQ Fell 9% on a $1.3 Billion Deal—Is Wall Street Missing Something?
- JPMorgan Earnings Miss Estimates But Reveal Broad-Based Strength
Receive News & Ratings for Molecule Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molecule Group and related companies with MarketBeat.com's FREE daily email newsletter.
